Document:

Exhibit 4.10

         THESE  SECURITIES HAVE NOT BEEN REGISTERED  UNDER THE SECURITIES ACT OF
         1933, AS AMENDED,  OR THE  SECURITIES  LAWS OF ANY STATE AND MAY NOT BE
         SOLD OR OFFERED  FOR SALE IN THE ABSENCE OF AN  EFFECTIVE  REGISTRATION
         STATEMENT FOR THE SECURITIES OR AN OPINION OF COUNSEL OR OTHER EVIDENCE
         ACCEPTABLE TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.

                            FOCUS ENHANCEMENTS, INC.

                          COMMON STOCK PURCHASE WARRANT

         1. Issuance; Certain Definitions. In consideration of good and valuable
consideration,   the   receipt  of  which  is  hereby   acknowledged   by  FOCUS
ENHANCEMENTS, INC., a Delaware corporation (the "Company"),VFINANCE INVESTMENTS,
INC.  or  registered  assigns  (the  "Holder")  is hereby  granted  the right to
purchase at any time until 5:00 P.M.,  New York City time,  on November 25, 2006
(the "Expiration  Date"),  Twenty-Two  Thousand Four Hundred (22,400) fully paid
and  nonassessable  shares of the Company's  Common  Stock,  $0.01 par value per
share  (the  "Common  Stock"),  at an  initial  exercise  price per  share  (the
"Exercise Price") of $1.20 per share, subject to further adjustment as set forth
herein.

         2. Exercise of Warrants.

                  (a) This  Warrant  is  exercisable  in whole or in part at any
time and from time to time.  Such exercise shall be effectuated by submitting to
the Company  (either by delivery to the Company or by facsimile  transmission as
provided in Section 8 hereof) a completed and duly  executed  Notice of Exercise
(substantially  in the  form  attached  to this  Warrant)  as  provided  in this
paragraph. The date such Notice of Exercise is faxed to the Company shall be the
"Exercise  Date,"  provided that the Holder of this Warrant tenders this Warrant
Certificate to the Company within five (5) business days thereafter.  The Notice
of Exercise  shall be executed by the Holder of this Warrant and shall  indicate
the number of shares  then  being  purchased  pursuant  to such  exercise.  Upon
surrender of this Warrant Certificate,  together with appropriate payment of the
Exercise  Price for the shares of Common  Stock  purchased,  the Holder shall be
entitled to receive a certificate or certificates for the shares of Common Stock
so purchased.

                  (b) The  Exercise  Price  per  share of  Common  Stock for the
shares then being exercised shall be payable in cash or by certified or official
bank check.

                  (c) In no event shall Holder  exercise  Warrants for less than
one thousand  (1,000) Warrant  Shares.  In the event the Holder has Warrants for
less than one  thousand  (1,000)  Warrant  Shares,  Holder  shall be required to
exercise Warrants for all remaining Warrant Shares on the Exercise Date.

                  (d) The Holder  shall be deemed to be the holder of the shares
issuable  to it in  accordance  with the  provisions  of this  Section  2 on the
Exercise Date.

         3.  Reservation of Shares.  The Company hereby agrees that at all times
during the term of this  Warrant  there  shall be  reserved  for  issuance  upon
exercise of this  Warrant  such number of shares of its Common Stock as shall be
required for issuance upon exercise of this Warrant (the "Warrant Shares").

<PAGE>

         4.  Mutilation  or Loss of  Warrant.  Upon  receipt  by the  Company of
evidence  satisfactory  to it of the loss,  theft,  destruction or mutilation of
this  Warrant,  and (in the  case of  loss,  theft or  destruction)  receipt  of
reasonably  satisfactory  indemnification,  and (in the case of mutilation) upon
surrender and cancellation of this Warrant, the Company will execute and deliver
a new  Warrant of like tenor and date and any such lost,  stolen,  destroyed  or
mutilated Warrant shall thereupon become void.

         5. Rights of the Holder.  The Holder  shall not, by virtue  hereof,  be
entitled to any rights of a stockholder in the Company, either at law or equity,
and the rights of the Holder are limited to those  expressed in this Warrant and
are not enforceable against the Company except to the extent set forth herein.

         6. Protection Against Dilution and Other Adjustments.

                  6.1  Adjustment  Mechanism.  If an  adjustment of the Exercise
Price is required  pursuant to this  Section 6, the Holder  shall be entitled to
purchase such number of additional  shares of Common Stock as will cause (i) the
total number of shares of Common  Stock Holder is entitled to purchase  pursuant
to this Warrant,  multiplied by (ii) the adjusted  Exercise Price per share,  to
equal  (iii) the  dollar  amount of the total  number of shares of Common  Stock
Holder  is  entitled  to  purchase  before  adjustment  multiplied  by the total
Exercise Price immediately before adjustment.

                  6.2 Capital Adjustments. In case of any stock split or reverse
stock   split,   stock   dividend,   reclassification   of  the  Common   Stock,
recapitalization,  merger or consolidation, or like capital adjustment affecting
the Common  Stock of the Company  prior to the  exercise of this  Warrant or its
applicable portion, the provisions of this Section 6 shall be applied as if such
capital adjustment event had occurred  immediately prior to the exercise date of
this Warrant and the original  Exercise  Price had been fairly  allocated to the
stock  resulting  from  such  capital  adjustment;  and in  other  respects  the
provisions of this Section shall be applied in a fair,  equitable and reasonable
manner so as to give effect, as nearly as may be, to the purposes hereof.

                  6.3 Spin Off.  If, for any  reason,  prior to the  exercise of
this Warrant in full,  the Company  spins off or otherwise  divests  itself of a
part of its business or operations or disposes all or of a part of its assets in
a  transaction   (the  "Spin  Off")  in  which  the  Company  does  not  receive
compensation for such business,  operations or assets,  but causes securities of
another entity to be issued to security holders of the Company, then the Company
shall  notify the Holder at least thirty (30) days prior to the record date with
respect to such Spin-Off.

         7. Transfer to Comply with the Securities Act; Registration Rights.

                  7.1 Transfer.  This Warrant has not been registered  under the
Securities  Act of 1933,  as  amended,  (the  "Act") and has been  issued to the
Holder  for  investment  and not with a view to the  distribution  of either the
Warrant or the Warrant Shares.  Except for transfers to officers,  employees and
affiliates of the Holder,  neither this Warrant nor any of the Warrant Shares or
any other security issued or issuable upon exercise of this Warrant may be sold,
transferred, pledged or hypothecated in the absence of an effective registration
statement  under the Act  relating  to such  security  or an  opinion of counsel
satisfactory  to the Company that  registration  is not required  under the Act.
Each  certificate  for the Warrant,  the Warrant  Shares and any other  security
issued or issuable  upon  exercise of this Warrant shall contain a legend on the
face  thereof,  in form and substance  satisfactory  to counsel for the Company,
setting forth the restrictions on transfer contained in this Section.

                                       2
<PAGE>

                  7.2  Registration   Rights.  (a)  Reference  is  made  to  the
Registration Rights Agreement.  The Company's obligations under the Registration
Rights Agreement and the other terms and conditions  thereof with respect to the
Warrant  Shares,  including,  but not  necessarily  limited  to,  the  Company's
commitment to file a registration  statement  including the Warrant  Shares,  to
have the  registration  of the Warrant Shares  completed and  effective,  and to
maintain such registration, are incorporated herein by reference.

                  (b) In addition to the registration  rights referred to in the
preceding  provisions of Section  7.2(a),  effective after the expiration of the
effectiveness of the Registration  Statement as contemplated by the Registration
Rights  Agreement,  the Holder shall have  piggy-back  registration  rights with
respect  to the  Warrant  Shares  then  held by the  Holder or then  subject  to
issuance upon exercise of this Warrant  (collectively,  the  "Remaining  Warrant
Shares"),  subject to the conditions set forth below.  If, at any time after the
Registration  Statement  has ceased to be  effective,  the Company  participates
(whether  voluntarily  or by reason of an  obligation  to a third  party) in the
registration  of any shares of the Company's stock (other than a registration on
Form S-8 or on Form S-4),  the Company shall give written  notice thereof to the
Holder and the Holder shall have the right, exercisable within ten (10) business
days after  receipt of such notice,  to demand  inclusion of all or a portion of
the Holder's  Remaining  Warrant Shares in such registration  statement.  If the
Holder exercises such election, the Remaining Warrant Shares so designated shall
be included in the  registration  statement  at no cost or expense to the Holder
(other than any costs or  commissions  which would be borne by the Holder  under
the terms of the Registration  Rights  Agreement);  provided,  however,  that if
there is a managing  underwriter  of the  offering of shares  referred to in the
registration  statement  and such  managing  underwriter  advises the Company in
writing that the number of shares  proposed to be included in the offering  will
have an adverse effect on its ability to successfully conclude the offering and,
as a  result,  the  number of shares to be  included  in the  offering  is to be
reduced,  the number of Remaining  Warrant Shares of the Holder which were to be
included in the  registration  (before such  reduction) will be reduced pro rata
with the number of shares  included for all other parties whose shares are being
registered.  The Holder's  rights under this Section 7 shall expire at such time
as the  Holder  can sell all of the  Remaining  Warrant  Shares  under  Rule 144
without volume or other restrictions or limit.

         8.  Notices.  Any notice or other  communication  required or permitted
hereunder  shall be in writing and shall be delivered  personally,  telegraphed,
sent by facsimile transmission or sent by certified, registered or express mail,
postage  pre-paid.  Any such  notice  shall be deemed  given  when so  delivered
personally,  telegraphed,  telexed  or sent by  facsimile  transmission,  or, if
mailed,  four days  after the date of deposit in the  United  States  mails,  as
follows:

                          (i) if to the Company, to:

                          FOCUS ENHANCEMENTS, INC.
                          1370 Dell Avenue
                          Campbell, California 95008
                          ATTN: Brett Moyer, President & Chief Executive Officer
                          Telephone No.: (408) 866-8300
                          Facsimile No.:  (408) 866-1748

                          with a copy to:

                          Manatt, Phelps & Phillips, LLP
                          1001 Page Mill Road, Bldg. 2
                          Palo Alto, California 94304
                          Attn: Jerrold F. Petruzzelli, Esq.
                          Telephone No.: (650) 812-1335
                          Telecopier No.: (650) 213-0260

                                       3
<PAGE>

                          (ii) if to the Holder, to:

                          vFinance Investments, Inc.
                          3010 North Military Trail
                          Suite 300
                          Boca Raton, FL 33431

                          with a copy to:

                          Krieger & Prager LLP, Esqs.
                          39 Broadway
                          Suite 1440
                          New York, NY 10006
                          Attn: Samuel M. Krieger, Esq.
                          Telephone No.: (212) 363-2900
                          Telecopier No.  (212) 363-2999

Any party may give notice in  accordance  with this Section to the other parties
designate to another address or person for receipt of notices hereunder.

         9.  Supplements and Amendments;  Whole  Agreement.  This Warrant may be
amended or  supplemented  only by an instrument in writing signed by the parties
hereto. This Warrant contains the full understanding of the parties with respect
to the  subject  matter  hereof and  thereof  and there are no  representations,
warranties,  agreements or understandings  other than expressly contained herein
and therein.

         10.  Governing  Law. This Warrant shall be deemed to be a contract made
under the laws of the State of Delaware for contracts to be wholly  performed in
such state and without  giving effect to the  principles  thereof  regarding the
conflict  of laws.  Each of the  parties  consents  to the  jurisdiction  of the
federal  courts whose  districts  encompass any part of the State of California,
Santa Clara County in connection with any dispute arising under this Warrant and
hereby waives, to the maximum extent permitted by law, any objection,  including
any  objection  based on  forum  non  conveniens,  to the  bringing  of any such
proceeding in such jurisdictions.

         11. JURY TRIAL WAIVER.  The Company and the Holder hereby waive a trial
by jury in any  action,  proceeding  or  counterclaim  brought  by either of the
parties  hereto  against  the other in respect of any matter  arising  out or in
connection with this Warrant.

         12.  Counterparts.  This  Warrant  may be  executed  in any  number  of
counterparts and each of such  counterparts  shall for all purposes be deemed to
be an original,  and all such counterparts shall together constitute but one and
the same instrument.

                                       4
<PAGE>

         13. Descriptive Headings.  Descriptive headings of the several Sections
of this  Warrant  are  inserted  for  convenience  only and shall not control or
affect the meaning or construction of any of the provisions hereof.

IN WITNESS WHEREOF, the parties hereto have executed this Warrant as of the 25th
day of November 2002.

                                              FOCUS ENHANCEMENTS, INC.

                                              By:/s/ Gary Williams
                                                 ------------------
                                                     Gary Williams
                                                     V.P. of Finance & CFO

                                       5

<PAGE>

                          NOTICE OF EXERCISE OF WARRANT

The undersigned hereby irrevocably elects to exercise the right,  represented by
the Warrant  Certificate  dated as of _____________,  ____________,  to purchase
shares of the Common Stock,  $0.01 par value, of FOCUS  ENHANCEMENTS,  INC., and
tenders  herewith  payment in  accordance  with  Section 1 of said Common  Stock
Purchase Warrant.

       CASH: $______________________ = (Exercise Price x Exercise Shares)

       Payment is being made by:
       ____  enclosed check

       ____  wire transfer

       ____  other

Please deliver the stock certificate to:

Dated:

[Name of Holder]

By:Exhibit 10.20

                         COMMON STOCK PURCHASE AGREEMENT

         THIS COMMON STOCK  PURCHASE  AGREEMENT is dated as of November 25, 2002
(this "Purchase  Agreement" or "Agreement"),  by and between FOCUS ENHANCEMENTS,
INC., a Delaware corporation,  having its principal place of business located at
1370 Dell Avenue,  Campbell,  California 95008 (the "Company"),  and each of the
Investors  listed on Schedule A hereto (the  "Investor",  and  collectively  the
"Investors").

                               W I T N E S S E T H

         WHEREAS,  the Company wishes to sell to the respective  Investors,  and
such  respective  Investors are willing to buy from the Company,  subject to the
terms and conditions set forth herein,  Eight Hundred Thousand  (800,000) shares
of Common Stock, par value $.01 per share (the "Common Stock"), of the Company.

         NOW, THEREFORE, for and in consideration of the premises and the mutual
agreement  contained herein and for other good and valuable  consideration,  the
receipt and  sufficiency  of which are hereby  acknowledged,  the parties hereto
agree as follows:

         A.  Definitions.  As used herein,  each of the following  terms has the
meaning set forth below, unless the context otherwise requires:

                  (i)  "Closing  Date"  means  the  date of the  closing  of the
purchase and sale of the Shares, as provided herein.

                  (ii) "Company  Control Person" means each director,  executive
officer,  promoter,  and such  other  Persons as may be deemed in control of the
Company  pursuant  to Rule 405 under the 1933 Act or  Section 20 of the 1934 Act
(as hereinafter defined).

                  (iii)  "Effective  Date"  means  the  effective  date  of  the
Registration  Statement covering the Registrable  Securities (as those terms are
defined in the Registration Rights Agreement) relating to the Shares.

                  (iv) "Escrow Funds" means the Purchase Price  delivered to the
Escrow Agent as contemplated by Sections 5(b) and (c) hereof.

                  (v) "Last Audited Date" means December 31, 2001.

<PAGE>

                  (vi) "Investor Control Person" means each director,  executive
officer,  promoter,  and such  other  Persons as may be deemed in control of the
Investor pursuant to Rule 405 under the 1933 Act or Section 20 of the 1934 Act.

                  (vii) "Majority In Interest" means Investors  owning in excess
of 51% of the Common Stock on the relevant date.

                  (viii) "Material Adverse Effect" means an event or combination
of events, which individually or in the aggregate,  would reasonably be expected
to (w) adversely affect the legality,  validity or  enforceability of the Shares
or any of the Transaction  Agreements,  (x) have or result in a material adverse
effect on the results of  operations,  assets,  or  financial  condition  of the
Company  and its  subsidiaries,  taken  as a whole,  (y)  adversely  impair  the
Company's  ability to perform fully on a timely basis its obligations  under any
of the Transaction  Agreements or the transactions  contemplated thereby, or (z)
materially and adversely affect the value of the rights granted to the Investors
in the Transaction Agreements.

                  (ix)  "Principal  Trading  Market"  means the NASDAQ  SmallCap
Market.

                  (x)  "Registration  Rights  Agreement"  means the Registration
Rights  Agreement  in the form  annexed  hereto as Annex IV, as executed by each
Investor and the Company simultaneously with the execution of this Agreement.

                  (xi) "Shares" means the shares of Common Stock.

                  (xii) "Transaction  Agreements" means this Purchase Agreement,
the Joint  Escrow  Instructions,  and the  Registration  Rights  Agreement,  and
includes all ancillary documents referred to in those agreements.

                  (xiii) "1933 Act" or "Securities Act" means the Securities Act
of 1933, as amended.

                  (xiv)  "1934  Act" or  "Exchange  Act"  means  the  Securities
Exchange Act of 1934, as amended.

         1. PURCHASE AND SALE; MUTUAL  DELIVERIES.  (a) Upon the following terms
and  conditions,  the  Company  shall  issue and sell to the  Investors  and the
Investors  shall purchase from the Company that number of shares of Common Stock
equal to Seven  Hundred and  Sixty-Eight  Thousand  Dollars  ($768,000.00)  (the
"Aggregate  Amount")  divided by the Purchase  Price (as  hereinafter  defined),
resulting in an aggregate of 800,000 shares (the "Shares") to be issued upon the
payment of the  Purchase  Price by the  respective  Investors in the amounts and
denominations set forth in Annex I. The Shares are part of an aggregate issuance
of 800,000 shares of Common Stock on  substantially  similar terms. The Purchase
Price is $0.96 per share.  The  Company's  obligation to sell the Shares to each
Investor and each  Investor's  obligation to purchase Shares from the Company is
several and represents a separate agreement. Upon receipt of the Purchase Price,
the Company shall deliver to the Investor one or more certificates  representing
the Shares, bearing substantially the following legend:

                  THE SECURITIES  REPRESENTED HEREBY (THE "SECURITIES") HAVE NOT
                  BEEN  REGISTERED  UNDER THE SECURITIES ACT OF 1933, AS AMENDED
                  (THE  "SECURITIES  ACT"),  OR THE SECURITIES LAWS OF ANY STATE
                  AND MAY NOT BE SOLD OR

                                       2
<PAGE>

                  OFFERED FOR SALE IN THE ABSENCE OF AN  EFFECTIVE  REGISTRATION
                  STATEMENT FOR THE SECURITIES OR AN OPINION OF COUNSEL OR OTHER
                  EVIDENCE  ACCEPTABLE TO THE CORPORATION THAT SUCH REGISTRATION
                  IS NOT REQUIRED.

                  (b) (i) The Investor acknowledges that (1) the Shares have not
been and are not  being  registered  under the  provisions  of the 1933 Act and,
except as provided in the Registration Rights Agreement or otherwise included in
an effective registration statement,  the Shares have not been and are not being
registered  under  the  1933  Act,  and  may  not  be  transferred   unless  (A)
subsequently  registered  thereunder or (B) the Investor shall have delivered to
the Company an opinion of counsel,  reasonably  satisfactory in form,  scope and
substance  to the  Company,  to  the  effect  that  the  Shares  to be  sold  or
transferred  may be sold or  transferred  pursuant  to an  exemption  from  such
registration;  (2)  any  sale  of the  Shares  made  in  reliance  on  Rule  144
promulgated  under the 1933 Act may be made only in accordance with the terms of
said Rule and further, if said Rule is not applicable, any resale of such Shares
under  circumstances in which the seller, or the Person through whom the sale is
made, may be deemed to be an underwriter,  as that term is used in the 1933 Act,
may require compliance with some other exemption under the 1933 Act or the rules
and regulations of the Securities and Exchange  Commission  ("Commission" or the
"SEC") thereunder; and (3) neither the Company nor any other Person is under any
obligation  to  register  the Shares  (other than  pursuant to the  Registration
Rights  Agreement) under the 1933 Act or to comply with the terms and conditions
of any exemption thereunder.

                      (ii) Within three (3) business  days (such third  business
day,  the  "Delivery  Date")  after the  business  day on which the  Company has
received a notice of sale (by facsimile or other  delivery),the  original Common
Stock  certificate (and if the same are not delivered to the Company on the same
date,  the date of delivery of the second of such items) from a given  Investor,
and any relevant state "blue sky" information (if necessary), the Company at its
expense,  (i) shall  deliver,  and shall  cause  legal  counsel  selected by the
Company  to  deliver,  to its  transfer  agent  (with  copies  to  Investor)  an
appropriate  instruction  and  opinion  of such  counsel,  for the  delivery  of
unlegended  Shares  issuable  pursuant  to the  registration  statement  for the
Shares;  provided that such registration  statement at the time of sale has been
declared  effective by the Commission and is current (the "Unlegended  Shares");
and (ii) transmit the certificates representing the Unlegended Shares (together,
unless otherwise instructed by the Investor, with Common Stock not sold), to the
Investor at the address  specified in a notice of sale (which address may be the
Investor's  address  for  notices  as  contemplated  by  Section  9 hereof  or a
different address) via express courier, by electronic transfer or otherwise.

                      (iii)  In  lieu  of   delivering   physical   certificates
representing  the  Unlegended   Shares,  if  the  Company's  transfer  agent  is
participating in the Depository Trust Company ("DTC") Fast Automated  Securities
Transfer  program,  upon  request of an  Investor  and its  compliance  with the
provisions contained in this paragraph,  so long as the certificates therefor do
not bear a legend and the  Investor  thereof  is not  obligated  to return  such
certificate  for the  placement of a legend  thereon,  the Company shall use its
best  efforts  to cause  its  transfer  agent  to  electronically  transmit  the
Unlegended  Shares by crediting the account of such Investor's Prime Broker with
DTC through its Deposit Withdrawal Agent Commission system.

                  (c) The Company shall also deliver,  or cause to be delivered,
the original or execution copies of this Purchase Agreement.

                                       3
<PAGE>

                  (d) There are no preemptive  rights of any  shareholder of the
Company,  as such, to acquire the Shares.  No party has a currently  exercisable
right  of  first  refusal  which  would  be  applicable  to  any  or  all of the
transactions contemplated by the Transaction Agreements.

         2.   REPRESENTATIONS  AND  WARRANTIES  OF  THE  COMPANY.   The  Company
represents and warrants to each respective Investor that:

                  (a) The Company has the corporate power and authority to enter
into this Purchase  Agreement,  and to perform its  obligations  hereunder.  The
execution  and  delivery  by the  Company  of this  Purchase  Agreement  and the
consummation by the Company of the  transactions  contemplated  hereby have been
duly  authorized by all necessary  corporate  action on the part of the Company.
This Purchase  Agreement has been duly executed and delivered by the Company and
constitute the valid and binding obligation of the Company  enforceable  against
it in  accordance  with its  respective  terms,  subject  to the  effects of any
applicable bankruptcy,  insolvency,  reorganization,  moratorium or similar laws
affecting creditors' rights generally and to general equitable principles.

                  (b) Except as set forth in the SEC Documents  (as  hereinafter
defined),  there is no pending, or to the knowledge of the Company,  threatened,
judicial,   administrative  or  arbitral  action,  claim,  suit,  proceeding  or
investigation which might affect the validity or enforceability of this Purchase
Agreement or which involves the Company and which if adversely determined, could
reasonably be expected to have a material  adverse effect on the Company and its
subsidiaries taken as a whole.

                  (c)  Except  as  contemplated  by  the   Registration   Rights
Agreement, no consent or approval of, or exemption by, or filing with, any party
or  governmental  or public body or authority is required in connection with the
execution,  delivery and performance under this Purchase Agreement or the taking
of any action contemplated hereunder or thereunder.

                  (d)  The  Company  has  been  duly  organized  and is  validly
existing as a corporation in good standing under the laws of the jurisdiction of
its incorporation.

                  (e) The execution,  delivery and  performance of this Purchase
Agreement by the Company, and the consummation of the transactions  contemplated
hereby,  will not (i) violate any  provision  of the  Company's  certificate  of
incorporation or bylaws, (ii) violate,  conflict with or result in the breach of
any of the terms  of,  result  in a  material  modification  of the  effect  of,
otherwise,  give  any  other  contracting  party  the  right  to  terminate,  or
constitute (or with notice or lapse of time or both constitute) a default under,
any  contract  or other  agreement  to which the  Company is a party or by or to
which the Company or any of the Company's  assets or properties  may be bound or
subject, (iii) violate any order, judgment,  injunction,  award or decree of any
court,  arbitrator or governmental  or regulatory body by which the Company,  or
the assets or  properties  of the  Company  are bound and (iv) to the  Company's
knowledge, violate any statute, law or regulation.

         3.  REPRESENTATIONS  AND  WARRANTIES  OF THE  INVESTORS.  Each Investor
hereby represents and warrants to the Company that:

                  (a) The  Investor  has the  corporate  power and  authority to
enter into this Purchase Agreement and to perform its obligations hereunder. The
execution  and  delivery by the  Investor of this  Purchase  Agreement,  and the
consummation by the Investor of the transactions  contemplated hereby, have been
duly authorized by all necessary corporate action on the part of

                                       4
<PAGE>

the Investor.  This  Purchase  Agreement has been duly executed and delivered by
the Investor and constitutes  the valid and binding  obligation of the Investor,
enforceable  against it in accordance with its respective terms,  subject to the
effects of any applicable bankruptcy, insolvency, reorganization,  moratorium or
similar laws  affecting  creditors'  rights  generally and to general  equitable
principles.

                  (b) The execution, delivery and performance by the Investor of
this Purchase Agreement,  and the consummation of the transactions  contemplated
hereby,  do not and will not breach or constitute a default under any applicable
law  or  regulation  or of any  agreement,  judgment,  order,  decree  or  other
instrument binding on the Investor.

                  (c) The  Investor  has such  knowledge  and prior  substantial
investment experience in financial and business matters, including investment in
non-listed and non-registered  securities, and has had the opportunity to engage
the services of an  investment  advisor,  attorney or accountant to read the SEC
Documents  and to evaluate the merits and risks of investment in the Company and
the Shares.

                  (d) The Investor is an  "accredited  investor" as that term is
defined in Rule 501(a) of Regulation D promulgated under the 1933 Act.

                  (e) [RESERVED]

                  (f) The  Investor  is  acquiring  the  Shares,  solely for the
Investor's  own  account  for  investment  and not with a view to or for sale in
connection with a distribution of any of the Shares.

                  (g) The Investor does not have a present intention to sell the
Shares, nor a present arrangement or intention to effect any distribution of any
of the  Shares to or  through  any person or entity  for  purposes  of  selling,
offering, distributing or otherwise disposing of any of the Shares.

                  (h) The Investor may be required to bear the economic  risk of
the investment indefinitely because none of the Shares may be sold, hypothecated
or otherwise disposed of unless subsequently registered under the Securities Act
and  applicable  state  securities  laws or an exemption  from  registration  is
available.  Any resale of any of the Shares can be made only  pursuant  to (i) a
registration  statement  under the Securities Act which is effective and current
at the  time  of  sale  or  (ii) a  specific  exemption  from  the  registration
requirements of the Securities Act. In claiming any such exemption, the Investor
will,  prior to any  offer or sale or  distribution  of any  Shares  advise  the
Company and, if requested,  provide the Company with a favorable written opinion
of counsel, in form and substance  satisfactory to counsel to the Company, as to
the applicability of such exemption to the proposed sale or distribution.

                  (i) The Investor  understands  that the exemption  afforded by
Rule 144  promulgated  by the  Commission  under the Securities Act ("Rule 144")
will not become available for at least one year from the date of payment for the
Shares and any sales in  reliance on Rule 144,  if then  available,  can be made
only in accordance with the terms and conditions of that rule, including,  among
other things, a requirement that the Company then be subject to, and current, in
its periodic  filing  requirements  under the  Exchange  Act,  and,  among other
things, a limitation on the amount of shares of Common Stock that may be sold in
specified time periods and the manner in which the sale can be made; that, while
the Company's  Common Stock is registered under the Exchange Act and the Company
is presently subject to the periodic reporting requirements of the

                                       5
<PAGE>

Exchange Act,  there can be no assurance that the Company will remain subject to
such reporting  obligations or current in its filing  obligations;  and that, in
case Rule 144 is not applicable to a disposition of the Shares,  compliance with
the  registration  provisions of the Securities Act or some other exemption from
such registration provisions will be required.

                  (j) The Investor  understands  that legends shall be placed on
the  certificates  evidencing  the Shares to the effect that the Shares have not
been registered under the Securities Act or applicable state securities laws and
appropriate  notations  thereof will be made in the Company's stock books.  Stop
transfer instructions will be placed with the transfer agent of the Shares.

                  (k) Except as set forth in the Term Sheet  between the Company
and vFinance Investments, Inc., dated October 24, 2002 the Investor has taken no
action  which  would  give  rise  to any  claim  by  any  person  for  brokerage
commission,  finder's  fees or similar  payments  by  Investor  relating to this
Purchase  Agreement or the transactions  contemplated  hereby. The Company shall
have no obligation  with respect to such fees or with respect to any claims made
by or on behalf of other persons for fees of a type contemplated in this Section
3(k) that may be due in connection with the  transactions  contemplated  hereby.
The Investor  shall  indemnify  and hold  harmless the Company,  its  employees,
officers, directors, agents, and partners, and their respective Affiliates, from
and  against  all  claims,  losses,  damages,  costs  (including  the  costs  of
preparation  and attorney's  fees) and expenses  suffered in respect of any such
claimed or existing fees, as and when incurred.

                  (l) The execution,  delivery and  performance of this Purchase
Agreement by the Investor, and the consummation of the transactions contemplated
hereby,  will  not  (i)  violate  any  provision  of  the  Investor's  corporate
organizational documents, (ii) violate, conflict with or result in the breach of
any of the terms  of,  result  in a  material  modification  of the  effect  of,
otherwise,  give  any  other  contracting  party  the  right  to  terminate,  or
constitute (or with notice or lapse of time or both constitute) a default under,
any  contract or other  agreement  to which the  Investor is a party or by or to
which the Investor or any of the Investor's assets or properties may be bound or
subject, (iii) violate any order, judgment,  injunction,  award or decree of any
court,  arbitrator or governmental or regulatory body by which the Investor,  or
the assets or  properties  of the Investor are bound and (iv) to the  Investor's
knowledge, violate any statute, law or regulation.

         4. COVENANTS OF THE COMPANY.

                  (a) Registration  Rights Agreement.  The Company covenants and
agrees to enter into a Registration  Rights Agreement governing the registration
of the Shares with the Investors dated as of the date hereof.

                  (b) Current Public  Information.  The Company has furnished or
made  available to each  Investor  true and correct  copies of all  registration
statements,  reports  and  documents,  including  proxy  statements  (other than
preliminary proxy  statements),  filed with the Commission by or with respect to
the Company  since  December  31, 2001 and prior to the date of this  Agreement,
pursuant to the  Securities  Act or the  Exchange  Act  (collectively,  the "SEC
Documents").  The SEC  Documents are the only filings made by or with respect to
the Company since December 31, 2001 pursuant to Sections  13(a),  13(c),  14 and
15(d) of the  Exchange  Act or pursuant to the  Securities  Act. The Company has
filed all reports,  schedules, forms, statements and other documents required to
be filed under  Sections  13(a),  13(c),  14 and 15(d) of the Exchange Act since
December 31, 2001 and prior to the date of this Agreement.

                                       6
<PAGE>

                  (c)  SEC  Documents.  The  Company  has  not  provided  to the
Investor any information  which according to applicable law, rule or regulation,
should have been disclosed  publicly prior to the date hereof by the Company but
which has not been so disclosed.  As of their respective dates or their restated
dates (if so restated),  the SEC Documents  complied,  and all similar documents
filed  with the SEC prior to the  Closing  Date  will  comply,  in all  material
respects with the requirements of the Securities Act or the Exchange Act, as the
case may be, and rules and  regulations  of the SEC  promulgated  thereunder and
other federal,  state and local laws,  rules and regulations  applicable to such
SEC  Documents,  and none of the SEC Documents  contained,  nor will any similar
document  filed  with the SEC prior to the  Closing  Date  contain,  any  untrue
statement  of a material  fact or omit to state a material  fact  required to be
stated therein or necessary in order to make the statements therein, in light of
the  circumstances  under which they were made,  not  misleading.  The financial
statements of the Company included in the SEC Documents, as of the dates thereof
(or the restated dates,  if so restated),  complied,  and all similar  documents
filed  with the SEC prior to the  Closing  Date will  comply,  as to form in all
material  respects with  applicable  accounting  requirements  and the published
rules and regulations of the SEC and other applicable rules and regulations with
respect  thereto.  Such financial  statements  were prepared in accordance  with
generally  accepted  accounting  principles applied on a consistent basis during
the periods involved (except (i) as may be otherwise indicated in such financial
statements  or the  notes  thereto  or (ii) in the  case  of  unaudited  interim
statements,  to the extent they may not include footnotes or may be condensed or
summary statements as permitted by Form 10-QSB of the SEC) and fairly present in
all material respects the financial position of the Company and its consolidated
subsidiaries as of the dates thereof and the consolidated  results of operations
and cash flows for the periods  then ended  (subject,  in the case of  unaudited
statements, to normal year-end audit adjustments).

                  (d) Absence of Certain  Changes.  Since the Last Audited Date,
there has been no material adverse change and no Material Adverse Effect, except
as disclosed in the Company's SEC Documents. Since the Last Audited Date, except
as provided in the  Company's  SEC  Documents or  disclosed  in the  Transaction
Documents,  the Company has not (i)  incurred or become  subject to any material
liabilities (absolute or contingent) except liabilities incurred in the ordinary
course of business consistent with past practices;  (ii) discharged or satisfied
any material lien or  encumbrance  or paid any material  obligation or liability
(absolute or contingent),  other than current  liabilities  paid in the ordinary
course of business  consistent with past  practices;  (iii) declared or made any
payment or distribution  of cash or other property to shareholders  with respect
to its capital  stock,  or  purchased  or redeemed,  or made any  agreements  to
purchase or redeem,  any shares of its  capital  stock;  (iv) sold,  assigned or
transferred any other tangible assets,  or canceled any debts or claims,  except
in the ordinary course of business consistent with past practices;  (v) suffered
any substantial losses or waived any rights of material value, whether or not in
the ordinary course of business,  or suffered the loss of any material amount of
existing business; (vi) made any changes in employee compensation, except in the
ordinary course of business consistent with past practices; or (vii) experienced
any material  problems with labor or management in connection with the terms and
conditions of their employment.

                  (e)  Absence  of  Litigation.   Except  as  disclosed  in  the
Company's SEC Documents,  (i) there is no action, suit,  proceeding,  inquiry or
investigation  before or by any court,  public  board or body pending or, to the
knowledge of the Company,  threatened against or affecting the Company before or
by any governmental authority or nongovernmental department,  commission, board,
bureau,  agency or instrumentality  or any other Person,  wherein an unfavorable
decision,  ruling or finding would have a Material Adverse Effect or which would
adversely affect the validity or enforceability  of, or the authority or ability
of the  Company  to  perform  its  obligations  under,  any  of the  Transaction
Agreements; (ii) the Company is not aware

                                       7
<PAGE>

of any valid  basis  for any such  claim  that  (either  individually  or in the
aggregate  with all other such events and  circumstances)  could  reasonably  be
expected to have a Material Adverse Effect; or (iii) there are no outstanding or
unsatisfied judgments,  orders, decrees,  writs,  injunctions or stipulations to
which the Company is a party or by which it or any of its  properties  is bound,
that  involve  the  transaction  contemplated  herein  or that,  alone or in the
aggregate, could reasonably be expect to have a Material Adverse Effect.

                  (f) [RESERVED]

                  (g) [RESERVED]

                  (h) No Undisclosed  Liabilities or Events.  The Company has no
liabilities  or  obligations  other  than  those  disclosed  in the  Transaction
Agreements  or the  Company's  SEC  Documents or those  incurred in the ordinary
course  of the  Company's  business  since  the  Last  Audited  Date,  or  which
individually  or in the aggregate,  do not or would not have a Material  Adverse
Effect.  No event or  circumstances  has  occurred or exists with respect to the
Company or its properties, business, operations, financial condition, or results
of operations, which, under applicable law, rule or regulation,  requires public
disclosure or announcement prior to the date hereof by the Company but which has
not  been so  publicly  announced  or  disclosed.  Except  as set  forth  in the
Company's  definitive  proxy  statement filed with the SEC on November 11, 2002,
there are no proposals currently under consideration or currently anticipated to
be under  consideration  by the Board of Directors or the executive  officers of
the Company which proposal would (x) change the certificate of  incorporation or
other charter  document or by-laws of the Company,  each as currently in effect,
with or without  shareholder  approval,  which  change would reduce or otherwise
adversely  affect the rights and powers of the  shareholders of the Common Stock
or (y) materially or substantially change the business, assets or capital of the
Company, including its interests in subsidiaries.

                  (i)   Trading  in   Securities.   The   Company   specifically
acknowledges that, except to the extent  specifically  provided herein or in any
of the other Transaction  Agreements (but limited in each instance to the extent
so specified),  and subject to applicable state and federal securities laws, the
Investor retains the right (but is not otherwise obligated) to buy, sell, engage
in  hedging  transactions  or  otherwise  trade in the  Shares  of the  Company,
including,  but not  necessarily  limited  to, the Shares,  at any time  before,
contemporaneous  with or after the execution of this Purchase  Agreement or from
time to time and in any manner  whatsoever  permitted by applicable  federal and
state securities laws.

                  (j) Fees to Brokers,  Finders and Others.  Except as set forth
in the Term Sheet  between the  Company and  vFinance  Investments,  Inc.  dated
October 24,  2002,  the Company has taken no action which would give rise to any
claim by any person for brokerage commission,  finder's fees or similar payments
by  the  Company  relating  to  this  Purchase  Agreement  or  the  transactions
contemplated hereby. Investor shall have no obligation with respect to such fees
or with respect to any claims made by or on behalf of other  persons for fees of
a type  contemplated in this Section 4(j) that may be due in connection with the
transactions  contemplated hereby. The Company shall indemnify and hold harmless
each of Investor, its employees,  officers, directors, agents, and partners, and
their respective Affiliates, from and against all claims, losses, damages, costs
(including the costs of preparation and attorney's  fees) and expenses  suffered
in respect of any such claimed or existing fees, as and when incurred.

                                       8
<PAGE>

                  (k)  Use of  Proceeds.  The  Company  will  use  the  proceeds
received  hereunder  (excluding  amounts  paid by the  Company  for legal  fees,
finder's fees and escrow fees in connection with the sale of the Shares) for the
purposes  contemplated by the schedule attached hereto as Annex VII, and, unless
specifically  consented to in advance in each instance by a majority in interest
of the  Investors,  the  Company  shall not,  directly or  indirectly,  use such
proceeds for any loan to or  investment  in any other  corporation,  partnership
enterprise  or  other  Person,  including  any of  its  Affiliates,  or for  the
repayment of any  outstanding  loan by the Company to any other party or for any
purpose constituting a material change from such schedule.

                  (l) [Reserved]

                  (m) [Reserved]

                  (n) [Reserved]

                  (o) [Reserved]

                  (p) [Reserved]

         5. DELIVERY OF SHARES.

                  (a) In accordance with the Joint Escrow Instructions, attached
hereto as Annex II and made a part hereof,  promptly  following  the delivery by
the  respective  Investor  of the  respective  Purchase  Price for the Shares in
accordance  with  Section 1 hereof,  the Company will  irrevocably  instruct its
transfer agent to issue to such Investor legended certificates  representing the
Shares.

                  (b) Form of Payment; Delivery of Certificates:

                      (i) The  respective  Investor shall pay the Purchase Price
for the Shares by delivering  immediately  available good funds in United States
Dollars to the Escrow Agent no later than the date prior to the Closing Date.

                      (ii) No later  than the  Closing  Date,  but in any  event
promptly following payment by the respective Investor to the Escrow Agent of the
Purchase  Price,  the Company  shall  deliver the Shares,  each duly executed on
behalf of the Company and issued in the name of the respective Investor,  to the
Escrow Agent.

                      (iii) By signing this Agreement,  each respective Investor
and the Company, subject to acceptance by the Escrow Agent, agrees to all of the
terms and conditions of, and becomes a party to, the Joint Escrow  Instructions,
all of the provisions of which are  incorporated  herein by this reference as if
set forth in full.

                  (c) Method of Payment.  Payment  into  escrow of the  Purchase
Price shall be made by wire transfer of funds to:

                           Bank of New York
                           350 Fifth Avenue
                           New York, New York 10001

                           ABA# 021000018
                           For credit to the account of Krieger & Prager LLP
                           Account No.:   637-2993136
                           Re: FOCUS Transaction

                                       9
<PAGE>

                  (d) [RESERVED]

                  (e) [RESERVED]

         6. CLOSING DATE.

                  a. The Closing Date shall occur on the date which is the first
NYSE trading day after each of the conditions  contemplated  by Sections 7 and 8
hereof  shall have  either been  satisfied  or been waived by the party in whose
favor such conditions run.

                  b. The  closing of the  purchase  and  issuance  of the Shares
shall  occur on the Closing  Date at the  offices of the Escrow  Agent and shall
take  place no later than 3:00  P.M.,  New York time,  on such day or such other
time as is mutually agreed upon by the Company and a majority in interest of the
Investors.

                  c. Notwithstanding  anything to the contrary contained herein,
the Escrow Agent will be  authorized  to release the Escrow Funds to the Company
and to others and to release the other Escrow  Property on the Closing Date upon
satisfaction  of the  conditions  set forth in  Sections  7 and 8 hereof  and as
provided in the Joint Escrow Instructions.

         7. CONDITIONS TO THE COMPANY'S OBLIGATION TO SELL.

         Each Investor  understands  that the  Company's  obligation to sell the
Shares to such  Investor  pursuant  to this  Agreement  on the  Closing  Date is
conditioned upon:

                  a. The execution  and delivery of this Purchase  Agreement and
the Registration Rights Agreement by such Investor;

                  b. Delivery by such Investor to the Escrow Agent of good funds
as payment in full of an amount  equal to the  Purchase  Price for the Shares in
accordance with this Purchase Agreement;

                  c. The accuracy on such  Closing  Date of the  representations
and warranties of such Investor contained in this Purchase Agreement, each as if
made on such date,  and the  performance by such Investor on or before such date
of all covenants and  agreements of the Investor  required to be performed on or
before such date; and

                  d. There  shall not be in effect any law,  rule or  regulation
prohibiting or restricting the transactions  contemplated  hereby,  or requiring
any consent or approval which shall not have been obtained.

         8. CONDITIONS TO THE INVESTORS' OBLIGATION TO PURCHASE.

                  The  Company   understands  that  the  respective   Investor's
obligation to purchase the Shares on the Closing Date is conditioned upon:

                  a. The execution  and delivery of this Purchase  Agreement and
the other Transaction Agreements by the Company;

                                       10
<PAGE>

                  b.  Delivery  by  the  Company  to  the  Escrow  Agent  of the
Certificates in accordance with this Purchase Agreement;

                  c. The accuracy in all material  respects on such Closing Date
of the  representations and warranties of the Company contained in this Purchase
Agreement,  each as if made on such date, and the  performance by the Company on
or before such date of all covenants and  agreements of the Company  required to
be performed on or before such date;

                  d. On such Closing Date,  the  Registration  Rights  Agreement
shall be in full  force and  effect  and the  Company  shall  not be in  default
thereunder;

                  e. On such Closing Date,  the  respective  Investor shall have
received  an opinion of counsel  for the Company  (and  delivered  to the Escrow
Agent),  dated  the  Closing  Date,  in form,  scope  and  substance  reasonably
satisfactory to the Investor, substantially to the effect set forth in Annex III
attached hereto;

                  f. There  shall not be in effect any law,  rule or  regulation
prohibiting or restricting the transactions  contemplated  hereby,  or requiring
any consent or approval which shall not have been obtained; and

                  g.  From and  after  the date  hereof  to and  including  such
Closing Date, each of the following  conditions  will remain in effect:  (i) the
trading of the Common  Stock shall not have been  suspended by the SEC or on the
Principal  Trading  Market;  (ii) no minimum prices shall been  established  for
Shares traded on the Principal  Trading  Market;  and (iii) there shall not have
been any material adverse change in any financial market that, in the reasonable
judgment of the Investor,  makes it impracticable or inadvisable to purchase the
Shares.  In  addition,  on the  Closing  Date,  trading  in  Common  Stock or in
securities  generally  on the  Principal  Trading  Market  shall  not have  been
suspended or limited

         9. NOTICES.  Any notice required or permitted  hereunder shall be given
in writing (unless otherwise  specified herein) and shall be deemed  effectively
given upon  personal  delivery or seven (7) business  days after  deposit in the
United States Postal Service,  by (a) advance copy by fax, and/or (b) mailing or
delivery by express  courier or  registered  or certified  mail with postage and
fees prepaid,  addressed to each of the other parties thereunto  entitled at the
following addresses,  or at such other addresses as a party may designate by ten
days advance written notice to each of the other parties hereto.

                      COMPANY:            FOCUS ENHANCEMENTS, INC.
                                          1370 Dell Avenue
                                          Campbell, California 95008
                                          ATTN: Brett Moyer, President & CEO
                                          Telephone No.: (408) 866-8300
                                          Facsimile No.:   (408) 866-1748

                      with a copy to:
                                          Manatt, Phelps & Phillips, LLP
                                          1001 Page Mill Road, Bldg. 2
                                          Palo Alto, California 94304
                                          Attn: Jerrold F. Petruzzelli, Esq.
                                          Telephone No.: (650) 812-1335
                                          Telecopier No.: (650) 213-0260

                                       11
<PAGE>

                      Investor:       As set forth on the execution page hereto.

                      with a copy to:     Krieger & Prager, LLP
                                          39 Broadway, Suite 1440
                                          New York, New York  10006
                                          ATTN:  Samuel Krieger, Esq.
                                          Telephone No.:  (212) 363-2900
                                          Facsimile No.:  (212) 363-2999

         10. SEVERABILITY.  If a court of competent jurisdiction determines that
any provision of this Purchase  Agreement is invalid,  unenforceable  or illegal
for any  reason,  such  determination  shall not affect or impair the  validity,
legality and  enforceability of the other provisions of this Purchase  Agreement
in  any  other  jurisdiction.  If  any  such  invalidity,   unenforceability  or
illegality of a provision of this Purchase  Agreement  becomes known or apparent
to any of the parties hereto,  the parties shall negotiate  promptly and in good
faith  in an  attempt  to  make  appropriate  changes  and  adjustments  to such
provision  specifically  and this  Purchase  Agreement  generally  to achieve as
closely as possible,  consistent  with  applicable law, the intent and spirit of
such provision specifically and this Purchase Agreement generally.

         11. EXECUTION IN COUNTERPARTS.  This Purchase Agreement may be executed
in  counterparts,  each of which shall be deemed an  original,  but all of which
together shall constitute the same Purchase Agreement.  A facsimile signature of
this Agreement shall be legal and binding on all parties hereto.

         12. JURY TRIAL  WAIVER.  The Company and the  Investors  hereby waive a
trial by jury in any action, proceeding or counterclaim brought by either of the
Parties hereto against any of the others in respect of any matter arising out or
in connection with the Transaction Agreements.

         13. GOVERNING LAW: MISCELLANEOUS.

                  a. This  Purchase  Agreement  shall be deemed to be a contract
made  under  the laws of the  State  of  Delaware  for  contracts  to be  wholly
performed  in such state and without  giving  effect to the  principles  thereof
regarding the conflict of laws. Each of the parties consents to the jurisdiction
of the  federal  courts  whose  districts  encompass  any  part of the  State of
California, Santa Clara County in connection with any dispute arising under this
Purchase  Agreement and hereby waives,  to the maximum extent  permitted by law,
any objection,  including any objection  based on forum non  conveniens,  to the
bringing of any such proceeding in such jurisdictions.

                  b.  Failure of any party to exercise any right or remedy under
this  Purchase  Agreement or otherwise,  or delay by a party in exercising  such
right or remedy, shall not operate as a waiver thereof.

                  c. This Purchase  Agreement  shall inure to the benefit of and
be binding upon the successors and assigns of each of the parties hereto.

                  d.  All  pronouns  and any  variations  thereof  refer  to the
masculine, feminine or neuter, singular or plural, as the context may require.

                                       12
<PAGE>

                  e. The headings of this Purchase Agreement are for convenience
of reference and shall not form part of, or affect the  interpretation  of, this
Purchase Agreement.

                  f. This  Agreement  may be amended  only by an  instrument  in
writing  signed by both parties;  no waiver shall be effective  unless signed by
the person charged with making such waiver.

                  g.  This  Agreement   supersedes  all  prior   agreements  and
understandings  among the  parties  hereto with  respect to the  subject  matter
hereof.

         14. SURVIVAL OF REPRESENTATIONS AND WARRANTIES.  The Company's and each
Investor's representations and warranties herein shall survive the execution and
delivery of this Purchase Agreement and the delivery of the Certificates and the
payment of the Purchase Price, and shall inure to the benefit of each respective
Investor and the Company and their respective successors and assigns.

                  [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

                                       13
<PAGE>

         IN  WITNESS  WHEREOF,  this  Agreement  has been duly  executed  by the
respective  Investor  (if an  entity,  by one of  its  officers  thereunto  duly
authorized) as of the date set forth below.

         AMOUNT AND PURCHASE PRICE OF COMMON STOCK: $
                                                     ----------------------

                                                SHARES:
                                                       --------------------

                             SIGNATURES FOR ENTITIES

         IN WITNESS  WHEREOF,  the  undersigned  represents  that the  foregoing
statements  are true  and  correct  and that it has  caused  this  Common  Stock
Purchase  Agreement to be duly executed on its behalf this 25th day of November,
2002.

         Address for Notices
         ________________________________   ___________________________________
         Address                            Printed Name of Investor
         ________________________________
                                            By: _______________________________
         Telecopier No. _________________      (Signature of Authorized Person)

                                            ___________________________________
                                            Printed Name and Title

If Investor is a partnership,  corporation,  limited  liability company or other
entity:

         I.  Jurisdiction where Investor's investment decision was made:

             _        Jurisdiction of mailing address listed above

             _        Other:   ____________________________

         II. Jurisdiction of Incorporation or Organization:________________

         As of the date set forth below,  the  undersigned  hereby  accepts this
Purchase  Agreement and  represents  that the foregoing  statements are true and
correct and that it has caused this  Purchase  Agreement to be duly  executed on
its behalf.

              FOCUS ENHANCEMENTS, INC.

              By:          /s/ Brett Moyer
                           -----------------
                           Brett Moyer
              Title:       President & CEO
              Date:        November 25, 2002

                                       14
<PAGE>

         IN  WITNESS  WHEREOF,  this  Agreement  has been duly  executed  by the
respective  Investor  (if an  entity,  by one of  its  officers  thereunto  duly
authorized) as of the date set forth below.

              AMOUNT AND PURCHASE PRICE OF COMMON STOCK: $268,000
                                                         --------
                                                     SHARES: 279,167
                                                             -------
                             SIGNATURES FOR ENTITIES

              IN WITNESS WHEREOF, the undersigned  represents that the foregoing
     statements  are true and correct  and that it has caused this Common  Stock
     Purchase  Agreement  to be duly  executed  on its  behalf  this 25th day of
     November, 2002.

              Address for Notices               SHIMSHON VISNSTEIN
              --------------------------------  ------------------
              Address                           Printed Name of Investor

              --------------------------------
                                                By: /s/ Shimshon Visnstein
                                                    ----------------------
              Telecopier No. _________________  (Signature of Authorized Person)

                                                ------------------------
                                                Printed Name and Title

         If Investor is a partnership, corporation, limited liability company or
other entity:

         I.  Jurisdiction where Investor's investment decision was made:

         _        Jurisdiction of mailing address listed above
         _        Other:   ____________________________

        II. Jurisdiction of Incorporation or Organization: ___________________

         As of the date set forth below,  the  undersigned  hereby  accepts this
Purchase  Agreement and  represents  that the foregoing  statements are true and
correct and that it has caused this  Purchase  Agreement to be duly  executed on
its behalf.

              FOCUS ENHANCEMENTS, INC.

              By:
                     --------------------------

                     Brett Moyer
              Title: President & CEO
              Date:  November 25, 2002

                                       14
<PAGE>

         IN  WITNESS  WHEREOF,  this  Agreement  has been duly  executed  by the
respective  Investor  (if an  entity,  by one of  its  officers  thereunto  duly
authorized) as of the date set forth below.

              AMOUNT AND PURCHASE PRICE OF COMMON STOCK: $500,000
                                                         --------
                                                    SHARES:520,833
                                                           -------

                             SIGNATURES FOR ENTITIES

         IN WITNESS  WHEREOF,  the  undersigned  represents  that the  foregoing
statements  are true  and  correct  and that it has  caused  this  Common  Stock
Purchase  Agreement to be duly executed on its behalf this 25th day of November,
2002.

         Address for Notices               ALPHA CAPITAL A.G.
         --------------------------------- ------------------
                                           Printed Name of Investor
         Address
         --------------------------------  By: /s/ Konrad Ackerman
                                               -------------------
         Telecopier No. _________________  (Signature of Authorized Person)

                                           Konrad Ackerman  Director
                                           -------------------------
                                           Printed Name and Title

         If Investor is a partnership, corporation, limited liability company or
other entity:

         I.  Jurisdiction where Investor's investment decision was made:

             _        Jurisdiction of mailing address listed above

             _        Other:   ____________________________

         II. Jurisdiction of Incorporation or Organization:___________________

         As of the date set forth below,  the  undersigned  hereby  accepts this
Purchase  Agreement and  represents  that the foregoing  statements are true and
correct and that it has caused this  Purchase  Agreement to be duly  executed on
its behalf.

              FOCUS ENHANCEMENTS, INC.

              By:          /s/ Brett Moyer
                           ---------------
                           Brett Moyer
              Title:       President & CEO
              Date:        November 25, 2002

                                       14

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00049-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00049-of-00352.parquet"}]]